Among all allergic diseases in pediatric practice, allergic rhinitis is one of the most common pathologies of the upper respiratory tract. This review deals with the problem of modern principles for the diagnosis and treatment of allergic rhinitis in children based on the analysis of literature sources using electronic databases PubMed, Web of Science, MedLine, the Cochrane Library. Allergic rhinitis is an important medical and social problem of our time the importance of which has increased significantly in recent years. The growing number of people sensitized to pollen, the variety of symptoms and the negative impact on the quality of life of patients make pollen allergy one of the major problems in pediatrics. Despite the development of international national protocols and clinical guidelines, in many countries the control of allergic rhinitis in children remains insufficient. Therefore, it is necessary to take into account the individual characteristics of patients, pay attention to both nasal and extranasal symptoms, consider all pathognomonic diagnostic aspects, because the underdiagnosis of this allergic disease leads to inadequate therapy, complications, more severe atopy and reduced quality of children’s life in general. Recently, there is growing evidence of the need for personalized selection of the most effective therapy for allergic rhinitis in children. In-depth study of the pathogenetic role of circadian molecular clock in children with seasonal allergic rhinitis using informative molecular genetic methods may allow characterizing in detail the mechanism of regulation of allergic inflammation of the upper airway mucosa and evaluating the role of circadian genes in the development of allergic diseases, in particular allergic rhinitis. In the future, these studies may become an alternative to improve control over the course of allergy and the organization of a comprehensive monitoring system, development of new strategies for the treatment and prevention of allergic rhinitis in children.
UCUkraine Municipal Enterprise «Children’s City Clinical Hospital Of The Poltava City Council»
Ukraine Municipal Enterprise «Children’s City Clinical Hospital Of The Poltava City Council»
The high prevalence of obesity among children and adolescents at the current stage is an important medical and social problem in pediatric practice. The presence of obesity in children is a significant risk factor for the development of metabolic disorders in the body. Pathogenetic mechanisms of the development of metabolic disorders in obese people remain to be fully understood, but the presence of a chronic inflammatory process in the body is considered to be one of the key factors in their formation. For today, many scientists are studying the state of the intestinal microbiota as one of the likely triggers of chronic inflammation and the development of metabolic changes in obese people. Purpose - to summarize the literature data and the results of our own research on the effectiveness of the therapeutic effect of probiotic cultures on the main metabolic indicators in children with obesity. Results and conclusions. At the current stage, scientific researches on the study the role of intestinal microbiota both as a marker of metabolic changes in the body of obese people and as a potential therapeutic target are continuing. According to systematic reviews, the level of pro-inflammatory cytokines in the body of obese people is significantly increased and pronounced dysbiotic disturbances are noted. Addition of probiotic cultures to therapy has been reported by various researchers to improve basic metabolic parameters and reduce inflammatory markers in obese people. As a result of our own research, improvements in carbohydrate and lipid metabolism indicators, the structural and functional state of the liver, and the general condition of obese children who took a synbiotic drug in complex treatment were revealed. The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of all participating institutions. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors.